
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded topical gel containing tannic acid, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
No product listing under the name tannic acid was found in the directory.
Gel bases can be aqueous or nonaqueous, and USP <795> classifies the preparation by its water activity. Aqueous preparations carry shorter default beyond-use dates than nonaqueous ones. The date printed on the label is the one to follow.
Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.
Tannic acid is a plant-derived astringent polyphenol that a pharmacy may compound, for example as a topical gel, when a prescriber orders it.
Tannic acid, or hydrolyzable gallotannin, is a complex polyphenol extracted from oak nutgalls, tara seed pods or sumac galls. It is an astringent: it binds and tightens proteins on the skin surface, forming a protective layer of firmer, constricted cells, and reduces secretions. There is no FDA-approved prescription tannic acid product. FDA lists tannic acid in 21 CFR 310.545 among OTC ingredients with inadequate data to establish general recognition of safety and efficacy for uses including skin protectant, astringent, diaper rash, fever blister and cold sore, poison ivy, anorectal astringent, and digestive aid products. FDA separately lists it in 21 CFR 184.1097 for limited food uses such as flavoring. The only DailyMed listing found is a 2013 combination first-aid spray. A prescriber might order tannic acid compounded as a topical preparation. Compounded preparations are not FDA-approved and require a prescription.
Tannic acid has no FDA drug label, so there is no boxed warning. The PubChem toxicology record (from the Hazardous Substances Data Bank) notes that tannic acid can be absorbed through broken or burned skin and cause serious body-wide toxicity, particularly liver damage, and that it can damage living tissue in burned areas; liver damage was seen in people who had tannic acid applied to extensive burns. It is described as moderately toxic if swallowed. Taken by mouth, it interferes with activated charcoal. Tell your prescriber if the area to be treated is a large burn or open wound. No pregnancy or breastfeeding data were found in the sources reviewed, and LactMed has no tannic acid record. Stop using it and talk to your prescriber or pharmacist if you notice skin irritation or other side effects.
Pharmaceutical-grade tannic acid is generally considered pentadigalloylglucose (PubChem/HSDB); it precipitates proteins, producing an astringent effect, and hydroxy and carboxy groups let it cross-link biopolymers and macromolecules (Youness et al., Molecules 2021). PubChem/HSDB describes former oral use for diarrhea, topical use for extensive burns and rectal use for rectal disorders, and topical use on bed sores and weeping ulcers; these are not FDA-approved indications, and FDA lists tannic acid in 21 CFR 310.545 as lacking adequate data for OTC skin protectant, astringent, anorectal, external analgesic and digestive aid uses. IJPC has published a compounding formulation for a tannic acid alcohol gel indexed as a topical skin astringent. Systemic absorption from denuded skin has been associated with hepatic necrosis, and gallic acid, a hydrolysis product, has been associated with renal injury (HSDB). Laboratory and anticancer findings in the Youness review are preclinical. Consider the extent of skin barrier disruption, and monitor for local irritation and, with large-area use on damaged skin, for signs of liver injury. Dosing is per prescriber.
Wash your hands. Apply the amount on your label to clean, dry skin and spread it in a thin layer. For a metered pump, your label states the number of presses. For a dosing syringe, push the plunger to the mark. Let the gel dry before covering with clothing. Wash your hands afterward and keep the site from touching other people until it has dried. Do not apply to broken skin unless told to.
A gel can have a nonaqueous or a water-based base, and USP <795> sets its default beyond-use date by water content, not by the word gel. A nonaqueous gel usually carries a beyond-use date of up to 180 days at room temperature or refrigerated. A water-based gel carries up to 35 days with a preservative, or 14 days refrigerated without one. Your label states which applies. Keep the container closed, away from heat and open flame if it contains alcohol, out of reach of children, and discard after the beyond-use date on your label.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)